MedPath

CLINICAL OUTCOMES OF BEVELED TIP, ULTRA-HIGH SPEED, 25-GAUGE PARS PLANA VITRECTOMY SYSTEM

Phase 4
Conditions
Vitreo-retinal diseases treatable by surgery
Registration Number
JPRN-UMIN000044421
Lead Sponsor
Peregrine Eye and Laser Institute
Brief Summary

The surgical objectives were achieved in all 50 eyes. The mean total operative time, core, shave and total vitrectomy times were 1891, 204, 330, 534 seconds, respectively. The mean number of surgical steps was 4.3. The mean number of times an ancillary instrument was placed inside the eye was 4.5. The mean CDVA at the three-month postoperative visit improved by 0.53 logMAR units (P=0.001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Significant Corneal opacification Scleral disorders Deficient capsular stability and integrity Inability to complete a 3 month follow up visits External eye infection Severe dry eye Glaucoma or ocular hypertension Prior glaucoma surgery Prior vitrectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ability of a 25-gauge, 10,000 CPM, bevel tip cutter probe to complete the surgical objectives for eyes undergoing PPV
Secondary Outcome Measures
NameTimeMethod
Presence of wound leak at end of surgery Pain assessment scores Postoperative intraocular pressures Core vitrectomy duration (from start of vitrectomy to shift to peripheral shaving setting) Frequency of need for adjunctive surgical instrumentation among eyes with proliferative retinopathy or proliferative diabetic retinopathy Adverse events (eg. retinal tear, retinal detachment)
© Copyright 2025. All Rights Reserved by MedPath